State of the Art
Clinical Pharmacology & Therapeutics (2008) 83, 26–36; doi:10.1038/sj.clpt.6100449
Advances in the Treatment of Breast Cancer
- 1Department of Breast Medical Oncology and Phase I Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
- 2Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Correspondence: S Moulder, (smoulder@mdanderson.org)
Received 11 October 2007; Accepted 12 October 2007; Published online 19 December 2007.
Top of page
Abstract
Breast cancer is the most commonly diagnosed cancer in American women and is the second leading cause of cancer-related deaths in this population. This review highlights how the use of a multidisciplinary approach to the management of diseases of the breast and the introduction of novel systemic therapies have improved the quality of life and survival in patients with breast cancer.
